SCHEMBL6131545

SCHEMBL6131545

C=CCC(C(N)=O)C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.40
GRIK2 Q13002 2/20 0.40
CYP2C19 P33261 2/20 0.39
TSHR P16473 3/20 0.38
ALDH1A1 P00352 2/20 0.38
FGFR4 P22455 1/20 0.38
CPA1 P15085 1/20 0.34
ABCC4 O15439 1/20 0.31
MAPT P10636 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30
BLM P54132 1/20 0.30
SLC6A3 Q01959 1/20 0.30
MEN1 O00255 1/20 0.30
CYP2D6 P10635 1/20 0.30
NFKB1 P19838 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1417130 0.85 GRIK1 (0.35) GRIK1GRIK2CYP2C19TSHRALDH1A1
SCHEMBL28326500 0.85 CYP2C19 (0.35) GRIK1GRIK2CYP2C19MAPT
SCHEMBL8921497 0.84 GRIK1 (0.34) GRIK1GRIK2TSHRALDH1A1FGFR4
SCHEMBL8927709 0.82 GRIK1 (0.37) GRIK1GRIK2CYP2C19CPA1
SCHEMBL174976 0.78 GRIK1 (0.50) GRIK1GRIK2CYP2C19TSHRALDH1A1
SCHEMBL31636 0.77 GRIK1 (0.48) GRIK1GRIK2CYP2C19TSHRALDH1A1
SCHEMBL6449828 0.76
SCHEMBL8251491 0.76
SCHEMBL1045132 0.76
SCHEMBL11763944 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021099336-A1 METHOD FOR IMPROVING COEFFICIENT OF FRICTION IN CURED FLUORORUBBER PARTS SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2021-05-27 WO claimed
EP-1343837-A1 FLUOROELASTOMER FILMS PREPARED BY PEROXIDE CURING A WATER-BORNE FLUOROELASTOMER COATING Lauren International, Inc. (US) 2003-09-17 EP claimed
US-20020111417-A1 Fluoroelastomer films prepared by peroxide curing a water-borne fluoroelastomer coating LAUREN INTERNATIONAL, INC. 2002-08-15 US claimed
WO-2002048251-A1 FLUOROELASTOMER FILMS PREPARED BY PEROXIDE CURING A WATER-BORNE FLUOROELASTOMER COATING LAUREN INTERNATIONAL, INC. (US) 2002-06-20 WO claimed
CN-119322176-B Biochip for simultaneously detecting multiple abundance markers and application thereof 中国科学院杭州医学研究所 2025-03-25 CN disclosed
CN-119322176-A Biochip for simultaneously detecting multiple abundance markers and application thereof 中国科学院杭州医学研究所 2025-01-17 CN disclosed
US-6958141-B2 Rhenium and technetium complexes containing a hypoxia-localizing moiety BRACCO INTERNATIONAL B.V. (NL) 2005-10-25 US disclosed
US-20040191174-A1 Rhenium and technetium complexes containing a hypoxia-localizing moiety BRACCO SUISSE SA (CH) 2004-09-30 US disclosed
US-6699458-B2 CELL MEMBRANE PERMEABILITIES GREATER THAN THAT OF SUCROSE BRACCO INTERNATIONAL B.V. (NL) 2004-03-02 US disclosed
US-20040010127-A1 RHENIUM AND TECHNETIUM COMPLEXES CONTAINING A HYPOXIA-LOCALIZING MOIETY BRACCO SUISSE SA (CH) 2004-01-15 US disclosed
EP-1343837-A1 FLUOROELASTOMER FILMS PREPARED BY PEROXIDE CURING A WATER-BORNE FLUOROELASTOMER COATING Lauren International, Inc. (US) 2003-09-17 EP disclosed
US-20020111417-A1 Fluoroelastomer films prepared by peroxide curing a water-borne fluoroelastomer coating LAUREN INTERNATIONAL, INC. 2002-08-15 US disclosed
US-5688487-A Diagnostic imaging methods using rhenium and technetium complexes containing a hypoxia-localizing moiety BRACCO INTERNATIONAL B.V. (NL) 1997-11-18 US disclosed
EP-0654025-A4 METHOD OF PREPARING OPTICALLY PURE PRECURSORS OF PAROXETINE. SEPRACOR INC (US) 1995-10-11 EP disclosed
EP-0654025-A1 METHOD OF PREPARING OPTICALLY PURE PRECURSORS OF PAROXETINE SEPRACOR, INC. (US) 1995-05-24 EP disclosed
EP-0417870-B1 Chelates for complexation of radioactive isotopes, their metal complexes and their use in diagnosis and therapy DIAGNOSTIKFORSCHUNG INST (DE) 1994-07-20 EP disclosed
US-5302370-A Form complexes with rhenium and technetium INSTITUT FUR DIAGNOSTIKFORSCHUNG GMBH (DE) 1994-04-12 US disclosed
WO-1994003428-A1 METHOD OF PREPARING OPTICALLY PURE PRECURSORS OF PAROXETINE SEPRACOR, INC. (US) 1994-02-17 WO disclosed
US-5258517-A Method of preparing optically pure precursors of paroxetine SEPRACOR, INC. (US) 1993-11-02 US disclosed
EP-0417870-A2 Chelates for complexation of radioactive isotopes, their metal complexes and their use in diagnosis and therapy INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN (DE) 1991-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040191174-A1 Rhenium and technetium complexes containing a hypoxia-localizing moiety HIF1A, HIF1AN, SLC2A8 GRIK1 2319/4885GRIK2 1781/4885CYP2C19 4764/4885
US-20040010127-A1 RHENIUM AND TECHNETIUM COMPLEXES CONTAINING A HYPOXIA-LOCALIZING MOIETY HIF1A, HIF1AN, SLC2A8 GRIK1 2319/4885GRIK2 1781/4885CYP2C19 4764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.